| Risk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic Diseases (NCT05476627) | Peking Union Medical College Hospital | 2022-07-01 |
| Assocaiton Between Uric Acid Trajecteries and Remission of NAFLD in NAFLD Individuals (NCT05245890) | Ningbo No. 1 Hospital | 2022-03-01 |
| Scintigraphy Study in Healthy Volunteers to Characterize the Performance of ALLN-346 Tablets (NCT05168683) | Allena Pharmaceuticals | 2022-01-11 |
| Febuxostat Versus Allopurinol on Hepatic Steatosis in MAFLD Patients (NCT05474560) | Ain Shams University | 2022-01-01 |
| Prediction of UA/SOD Ratio as a Biomarker of Oxidative Stress in Atrial Fibrillation (NCT06119802) | Yinglong Hou | 2022-01-01 |
| Treat-to-target by Email During Urate-lowering Therapy in Gout (NCT04733079) | Assistance Publique - Hôpitaux de Paris | 2021-12-15 |
| Tolerance, Pharmacokinetics / Pharmacodynamics (PK / PD) and Immunogenicity of Pegylated Uric Acid Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers (NCT05226013) | The Affiliated Hospital of Qingdao University | 2021-12-08 |
| Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients (NCT05119686) | Arthrosi Therapeutics | 2021-11-16 |
| Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects (NCT04966325) | LG Chem | 2021-09-23 |
| Possible Pharmacological Effect of Quercetin in the Management of Hyperuricemia - Results From Real-life Clinical Studies (NCT06652035) | Liaquat University of Medical & Health Sciences | 2021-09-01 |
| Clinical Effect Observation of Barley Green Intervention in Hyperuricemia Population and Related Mechanism Study of Xanthine Oxidase (NCT06876909) | Peking University People's Hospital | 2021-08-26 |
| Relative Bioavailability Study to Assess an LC350189 Tablet Compared to an LC350189 Capsule in Healthy Adults (NCT04886050) | LG Chem | 2021-07-31 |
| An Inpatient Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects (Study 201) (NCT04987242) | Allena Pharmaceuticals | 2021-07-16 |
| Research and Development of a New Technology for Detection of Abnormal Excretion of Intestinal Uric Acid Involved in the Incidence of Gout (NCT04953533) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-07-06 |
| Study 102: Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase) (NCT04829435) | Allena Pharmaceuticals | 2021-04-21 |
| Hyperuricemia and Diabetic Nephropathy (NCT04799925) | Assiut University | 2021-04-15 |
| Hmong Microbiome ANd Gout, Obesity, Vitamin C (HMANGO-C) (NCT04938024) | University of Minnesota | 2021-03-28 |
| Vegan Diet, Amla Fruits and Uric Acid (NCT04801745) | Fu Jen Catholic University | 2021-03-20 |
| Post-Authorisation Safety Study of Lesinurad (NCT04072471) | AstraZeneca | 2021-01-29 |
| A Study to Assess the Efficacy, Safety, and Pharmacokinetics of ABP-671 in Patients With Gout or Hyperuricemia (NCT04638543) | Atom Therapeutics Co., Ltd | 2020-11-27 |
| A Safety and Tolerability Study of FCN-207 in Healthy Volunteers (NCT04622124) | Fochon Pharmaceuticals, Ltd. | 2020-11-11 |
| Study on the Bioavailability of Three Different Prescription Processes of SHR4640 Tablets in Healthy Volunteers (NCT04586803) | Jiangsu HengRui Medicine Co., Ltd. | 2020-10-01 |
| ALLN-346 Single Ascending Dose (SAD) Study in Healthy Volunteers (NCT04236219) | Allena Pharmaceuticals | 2020-09-02 |
| Xanthine Oxidase and Uric Acid Origin in Preeclamptic Women (NCT04463940) | Barzilai Medical Center | 2020-06-30 |
| Role of Uralyt-U in Patients With Hyperuricemia (NCT04352153) | Ai Peng | 2020-04-01 |
| Urate Lowering Therapies and Left Ventricular Diastolic Dysfunction (NCT03534037) | National Defense Medical Center, Taiwan | 2020-02-01 |
| The Effect of Naproxen on the Pharmacokinetic Profile of LC350189 in Healthy Adults (NCT04139824) | LG Chem | 2020-01-22 |
| Uric Acid Lowering Trial in Youth Onset T2D (NCT03899883) | University of Colorado, Denver | 2020-01-01 |
| A Safety and Efficacy Study of SHR4640 and Febuxostat in Subjects With Hyperuricemia (NCT04180982) | Jiangsu HengRui Medicine Co., Ltd. | 2019-12-03 |
| A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia (NCT03934099) | LG Chem | 2019-12-02 |
| Renal PK Study of LC350189 (NCT04066712) | LG Chem | 2019-11-19 |
| Effect of the Consumption of a Combination of Plant Extracts (BSL_EP026) on Serum Uric Acid. (NCT04165499) | Biosearch S.A. | 2019-11-11 |
| The Effect of Colchicine on the Pharmacokinetic Profile of LC350189 in Healthy Aldults. (NCT03927677) | LG Chem | 2019-11-05 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 (NCT04060173) | Atom Therapeutics Co., Ltd | 2019-09-05 |
| Effects of Allopurinol on Inflammation and Ultrasonographic Changes in People With Elevated Uric Acid But no Symptoms (NCT04012294) | Instituto Nacional de Cardiologia Ignacio Chavez | 2019-08-30 |
| The Effects of Rhus Coriaria L. on Serum Uric Acid Levels (NCT02891031) | Shiraz University of Medical Sciences | 2019-06-01 |
| Uric Acid Reduction as a Novel Treatment for Pediatric Chronic Kidney Disease (NCT03865407) | Virginia Commonwealth University | 2019-03-10 |
| Effect of Oxalate and Urate Metabolism on CKD Evolution (NCT04399915) | The Institute of Nephrology of the Academy of Medical Sciences of Ukraine | 2019-01-10 |
| Placebo Controlled, Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAP-001 in Gout Patients (NCT04040816) | Shanton Pharma Co., Ltd. | 2019-01-01 |
| The Long Term Effect of Low Dose Aspirin on Uric Acid in Chinese Patients With Coronary Artery Disease（AURORA） (NCT03691688) | Shanghai Zhongshan Hospital | 2018-12-01 |
| Probiotics for Gout / Hyperuricemia: A Randomized, Intervention, Parallel Controlled, Multicenter Clinical Trial (NCT04199325) | The Affiliated Hospital of Inner Mongolia Medical University | 2018-11-01 |
| Sex-related Differences in Arterial Stiffness in Type 2 Diabetics: Role of Uric Acid (NCT03648996) | University of Missouri-Columbia | 2018-11-01 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 in Healthy Subjects (NCT03906006) | Atom Therapeutics Co., Ltd | 2018-10-17 |
| Nutraceutical on Hyperuricemia (NCT04161872) | University of Pavia | 2018-10-01 |
| The Diet Gout Trial (NCT03569020) | Johns Hopkins University | 2018-08-07 |
| The Relationship Among, Serum Uric Acid, Left Ventricular Hypertrophy and Metabolic Syndrome (NCT03473951) | National Defense Medical Center, Taiwan | 2018-03-26 |
| Prevalence of Hyperuricemia in Pakistan (NCT03473444) | OBS Pakistan | 2018-03-01 |
| Hyperuricemia and Left Ventricular Diastolic Function (NCT03495999) | National Defense Medical Center, Taiwan | 2017-08-01 |
| Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia (NCT03185793) | Jiangsu HengRui Medicine Co., Ltd. | 2017-07-20 |
| Lowering-hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients (NCT03200210) | Sun Yat-sen University | 2017-07-11 |
| Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid Level (NCT03211403) | Atridia Pty Ltd. | 2017-07-04 |
| Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria (NCT03118739) | AstraZeneca | 2017-05-18 |
| Gender Differences in the Metabolic Effects of Uric Acid (NCT03076684) | University of Missouri-Columbia | 2017-03-03 |
| Use of Febuxostat in Hyperuricemia Among Hemodialysis Patients (NCT03149939) | Benha University | 2017-01-01 |
| Effect of Hyperuricaemia on Chronic Renal Disease (NCT03425708) | The Affiliated Hospital of Xuzhou Medical University | 2017-01-01 |
| The Intervention of Multi-vitamin With Minerals to Hyperuricemia (NCT03218709) | Sun Yat-sen University | 2017-01-01 |
| The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics (NCT02956278) | University of California, San Francisco | 2016-11-01 |
| Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid (NCT02959918) | Selecta Biosciences, Inc. | 2016-10-01 |
| Compare the Renal Protective Effects of Febuxostat and Benzbromarone in CKD Chinese Patients (NCT02944214) | Shanghai 10th People's Hospital | 2016-10-01 |
| Study of FYU-981 in Hyperuricemia (Effect on Two Hyperuricemic Types) (NCT02837198) | Fuji Yakuhin Co., Ltd. | 2016-07-01 |
| Study of URC102 to Assess the Safety and Efficacy in Gout Patients (NCT02557126) | JW Pharmaceutical | 2015-10-01 |
| Pharmacogenetics of SGLT2 Inhibitors (NCT02462421) | University of Maryland, Baltimore | 2015-06-01 |
| Study of FYU-981 in Hyperuricemia With or Without Gout (NCT02416167) | Fuji Yakuhin Co., Ltd. | 2015-05-01 |
| Compare the Renal Protective Effects of Febuxostat and Benzbromarone (NCT02338323) | Shanghai 10th People's Hospital | 2015-01-01 |
| The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis Patients (NCT02338128) | Shanghai 10th People's Hospital | 2015-01-01 |
| Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout (NCT02252835) | Gilead Sciences | 2014-08-01 |
| Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients (NCT02290210) | JW Pharmaceutical | 2014-07-24 |
| Effect of Chrysanthemum Flower Oil and Its Dose-dependency on Hyperuricemia (NCT02213562) | Hiroshima University | 2014-07-01 |
| Study of FYU-981 in Hyperuricemia With or Without Gout (NCT02344862) | Fuji Yakuhin Co., Ltd. | 2014-01-01 |
| Long-term Prednisone Use for End-stage Heart Failure (NCT02282683) | Hebei Medical University | 2013-12-01 |
| Effect of Allopurinol Treatment on Insulin Resistance (NCT02008968) | Istanbul Medeniyet University | 2013-12-01 |
| Zurig (Febuxostat) 40mg Efficacy and Safety Trial (NCT02600780) | Getz Pharma | 2013-11-01 |
| Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy (NCT01984749) | Freed Study Group | 2013-11-01 |
| The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome (NCT01818505) | National Taiwan University Hospital | 2013-03-01 |
| Effect of Quercetin Supplements on Healthy Males: a Four-Week Randomized Cross-Over Trial (NCT01881919) | University of Leeds | 2013-02-01 |
| Purine Metabolism Enzyme SNP to Uric Acid Production (NCT01830725) | Keesler Air Force Base Medical Center | 2012-12-01 |
| Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout (NCT01519687) | Pharmos | 2012-01-01 |
| Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia (NCT02502565) | Washington D.C. Veterans Affairs Medical Center | 2012-01-01 |
| Impact of Blueberries on Uric Acid and Quality of Life (NCT01532622) | University of Mississippi Medical Center | 2012-01-01 |
| A Randomized, Double-Blind, Dose-Response Study of the Safety and Uric Acid Effects of Oral Ulodesine Added to Allopurinol in Subjects With Gout and Concomitant Moderate Renal Insufficiency (NCT01407874) | BioCryst Pharmaceuticals | 2011-09-01 |
| Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients (NCT01416402) | Gilead Sciences | 2011-08-01 |
| Safety, Tolerability and Pharmacokinetic/Pharmacodynamic Characteristics of LC350189 (NCT01361646) | LG Life Sciences | 2011-06-01 |
| Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout (NCT01336686) | Gilead Sciences | 2011-05-01 |
| Study to Evaluate sUA Lowering Activity, Safety and Efficacy of Oral Ulodesine Added to Allopurinol (NCT01265264) | BioCryst Pharmaceuticals | 2010-12-01 |
| Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO) (NCT01109121) | Nuon Therapeutics, Inc. | 2010-06-01 |
| Tart Cherry Juice and Markers of Inflammation, CVD, and Diabetes (NCT03636529) | University of Memphis | 2010-06-01 |
| Safety and Efficacy of TULY (Rasburicase) in Prevention and Treatment of Malignancy-associated Hyperuricemia (NCT00921375) | Virchow Group | 2010-02-01 |
| Study of Tranilast Alone or in Combination With Allopurinol in Subjects With Hyperuricemia (NCT01052987) | Nuon Therapeutics, Inc. | 2010-01-01 |
| Safety and Efficacy Study of Intramuscular Uricase-PEG 20 (NCT01038947) | EnzymeRx | 2009-12-01 |
| Study of Tranilast Alone or in Combination With Febuxostat in Patients With Hyperuricemia (NCT00995618) | Nuon Therapeutics, Inc. | 2009-09-01 |
| Gout Dose Response Study (NCT00955981) | Ardea Biosciences, Inc. | 2009-07-01 |
| Prednisone for Heart Failure Patients With Hyperuricemia (NCT00919243) | Hebei Medical University | 2009-02-01 |
| Lowering Serum Uric Acid to Prevent Acute Kidney Injury (NCT00756964) | University of Florida | 2008-10-01 |
| Primary Prevention of Hypertension in Obese Adolescents (NCT00288158) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2008-09-01 |
| A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout (NCT00741442) | Ardea Biosciences, Inc. | 2008-07-01 |
| The Effect of Uric Acid Decrement on Endothelial Function in Patients With Chronic Renal Failure (NCT00978653) | Istanbul University | 2008-04-01 |
| Rasburicase (Fasturtec) Registration Trial (NCT00607152) | Sanofi | 2007-10-01 |
| Effect of Reducing Uric Acid on Insulin Sensitivity and Oxidative Status (NCT01931527) | Washington University School of Medicine | 2006-07-01 |
| Traditional Chinese Medicine in the Treatment of Patients With Hyperuricemia. (NCT04144088) | Chung Shan Medical University | 2006-06-01 |
| Rasburicase in Tumor Lysis Syndrome (NCT00302653) | Sanofi | 2006-02-01 |